Why is the FDA leaving doctors in the dark?

By Sally Pipes

Published August 2, 2016 4:03am ET

Add Washington Examiner on Google

Why is the FDA leaving doctors in the dark? — Store-brand ibuprofen is chemically identical to Advil. Both will affect a patient the same, so there's no need for separate product labels. (AP Photo) | Paul Sancya

FDA officials apparently think that doctors aren’t smart enough to understand the labels on the medications they prescribe.

The agency recently released draft guidance for how the pharmaceutical industry should label “biosimilars,” a new class of medicines. These guidelines state that biosimilars’ labels should leave out critical information in order to avoid causing “confusion” among doctors.

Print subscriber? Click here to login/register your account

Digital subscriber? Click here to login/register your account.

Full midterm coverage.Deeper analysis.

Get unlimited access to Washington Examiner's reporting, expert analysis, and coverage of the midterm elections.

Get Unlimited Access

Cancel anytime.

Tag:

Commentary FDA Health Minusextra OpinionDigest Pharmaceutical Industry